Frontier Asset Management’s ExxonMobil XOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$604K Buy
4,414
+13
+0.3% +$1.95K 0.11% 67
2026
Q1
$747K Buy
4,401
+527
+14% +$76.9K 0.16% 59
2025
Q4
$466K Buy
3,874
+1,341
+53% +$156K 0.11% 65
2025
Q3
$286K Sell
2,533
-32
-1% -$3.56K 0.07% 66
2025
Q2
$277K Buy
2,565
+567
+28% +$60.6K 0.08% 67
2025
Q1
$238K Sell
1,998
-495
-20% -$54.7K 0.07% 63
2024
Q4
$268K Buy
2,493
+72
+3% +$8.42K 0.09% 62
2024
Q3
$284K Buy
2,421
+20
+0.8% +$2.31K 0.09% 62
2024
Q2
$276K Buy
2,401
+435
+22% +$50.7K 0.1% 56
2024
Q1
$229K Sell
1,966
-111
-5% -$11.6K 0.08% 58
2023
Q4
$208K Buy
2,077
+19
+0.9% +$2K 0.08% 58
2023
Q3
$242K Sell
2,058
-93
-4% -$10.2K 0.11% 54
2023
Q2
$231K Buy
2,151
+18
+0.8% +$1.96K 0.1% 53
2023
Q1
$234K Buy
2,133
+18
+0.9% +$1.99K 0.11% 50
2022
Q4
$233K Buy
+2,115
New +$227K 0.11% 52

Other funds holding XOM

Frontier Asset Management's XOM Position: Q2 2026 in Review

Frontier Asset Management increased its ExxonMobil (XOM) stake by 0.3% in Q2 2026, buying an estimated $1.95K and bringing the position to 4,414 shares worth $604K. The position accounts for 0.11% of the portfolio, ranked #67.

Frontier Asset Management first reported a position in XOM in Q4 2022 and has held it in 15 quarters since. The position peaked at $747K in Q1 2026. 4,249 funds tracked by Wall St. Rank hold XOM as of Q2 2026.

  • Frontier Asset Management held 4,414 shares of ExxonMobil worth $604K as of Q2 2026.
  • Frontier Asset Management bought 13 ExxonMobil shares in Q2 2026, an estimated $1.95K.
  • ExxonMobil made up 0.11% of Frontier Asset Management's portfolio in Q2 2026, its #67 holding.
  • Frontier Asset Management first reported a position in ExxonMobil in Q4 2022 and has held it in 15 quarters since.
  • Frontier Asset Management's ExxonMobil position peaked at $747K in Q1 2026.
  • 4,249 funds tracked by Wall St. Rank held ExxonMobil as of Q2 2026.

Based on Frontier Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.